Source: Journal of Pharmacy and Pharmacognosy Research. Conference titles: Colombian Congress of Pharmacology and Therapeutics. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, DIABETES MELLITUS, RESISTÊNCIA À INSULINA
ABNT
D'VRIES, R. et al. Development and synthesis of new molecules for the treatment of diabetes, metabolic syndrome and insulin resistance. Journal of Pharmacy and Pharmacognosy Research. Antofagasta: AVAGAX. Disponível em: https://doi.org/10.5281/zenodo.3663082. Acesso em: 05 set. 2024. , 2019APA
D'Vries, R., Delgado, S. V., Porras, L. M., Piñeros, O., & Ellena, J. (2019). Development and synthesis of new molecules for the treatment of diabetes, metabolic syndrome and insulin resistance. Journal of Pharmacy and Pharmacognosy Research. Antofagasta: AVAGAX. doi:10.5281/zenodo.3663082NLM
D'Vries R, Delgado SV, Porras LM, Piñeros O, Ellena J. Development and synthesis of new molecules for the treatment of diabetes, metabolic syndrome and insulin resistance [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2019 ; No 2019 S33.[citado 2024 set. 05 ] Available from: https://doi.org/10.5281/zenodo.3663082Vancouver
D'Vries R, Delgado SV, Porras LM, Piñeros O, Ellena J. Development and synthesis of new molecules for the treatment of diabetes, metabolic syndrome and insulin resistance [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2019 ; No 2019 S33.[citado 2024 set. 05 ] Available from: https://doi.org/10.5281/zenodo.3663082